KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Receivables - Net: 2009-2025

Historic Receivables - Net for Novavax (NVAX) over the last 11 years, with Sep 2025 value amounting to $41.8 million.

  • Novavax's Receivables - Net fell 59.23% to $41.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year decrease of 59.23%. This contributed to the annual value of $116.0 million for FY2024, which is 61.97% down from last year.
  • Novavax's Receivables - Net amounted to $41.8 million in Q3 2025, which was down 82.12% from $234.1 million recorded in Q2 2025.
  • Novavax's 5-year Receivables - Net high stood at $478.2 million for Q1 2022, and its period low was $29.1 million during Q1 2024.
  • For the 3-year period, Novavax's Receivables - Net averaged around $143.7 million, with its median value being $116.0 million (2024).
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 740.37% in 2022, then crashed by 90.12% in 2024.
  • Quarterly analysis of 5 years shows Novavax's Receivables - Net stood at $455.0 million in 2021, then plummeted by 78.85% to $96.2 million in 2022, then spiked by 216.93% to $304.9 million in 2023, then plummeted by 61.97% to $116.0 million in 2024, then tumbled by 59.23% to $41.8 million in 2025.
  • Its Receivables - Net stands at $41.8 million for Q3 2025, versus $234.1 million for Q2 2025 and $52.2 million for Q1 2025.